Onterris, Inc.

MEGActive

CIK 1643615 · Core Solid Waste & Recycling

N/A

Market data as of N/A

Financials: LTM / latest available company filings

Sources: FMP, MEG filings, SEC EDGAR

$585

Market cap ($MM)

$963

Enterprise value ($MM)

$821

Revenue · LTM ($MM)

$77

EBITDA · LTM ($MM)

EBITDA margin

1.2x

EV / revenue

11.3x

EV / EBITDA

3.9x

Net debt / EBITDA

Coverage

Coverage view

The analytical read on the name and the balance-sheet capacity behind the program.

Key points

01MEG is a scaled public consolidator in Solid Waste, a benchmark for how the sub-sector buys, pays, and trades.
02The relevant peer set is WM, RSG, WCN, CLH, GFL, CWST.

Balance sheet & capacity

Indicative capacity read: 3.9x net debt / EBITDA with EBITDA of $76.6MM.

$10

Cash & equiv. ($MM)

$310

Total debt ($MM)

$300

Net debt ($MM)

3.9x

Net debt / EBITDA

Valuation

Where it trades against its peer set

MEG versus the scaled public Core Solid Waste & Recycling comparables.

Indexed share-price performance

MEG versus available Core Solid Waste & Recycling peers and SPY.

-67%

MEG

N/A

Peer med.

+79%

SPY

Indexed to 100 from May 28, 2021 through May 22, 2026. Source: FMP month-end close history.

Company	Ticker	Revenue ($MM)	EBITDA ($MM)	Margin	Market cap ($MM)	EV ($MM)	EV / rev	EV / EBITDA	Net debt / EBITDA
Onterris, Inc.	MEG	$821	$77	9%	$585	$963	1.2x	11.3x	3.9x

Financials via Financial Modeling Prep (SEC-derived TTM). EV/EBITDA distribution: each dot a live peer, band = interquartile range, line = median. Impossible values (EBITDA > revenue, negative-EBITDA multiples) shown NM.

M&A program

A sustained, programmatic tuck-in cadence

MEG's disclosed acquisition footprint and the deals behind it.

Disclosed acquisitions

Active years

Named deals

Avg / active year

7.4

Acq. cash outflow ($MM)

N/A

Banker read

01MEG reads as a programmatic acquirer: 37 disclosed acquisitions across 5 active years, or 7.4 per active year. The chart shows activity in 5 of the last 5 visible years.
02In the last three years, the file shows 16 acquisitions versus 9 in the prior three; recent activity is running above the prior three-year period.
03Spend changes the read: $387MM of disclosed spend is concentrated in lumpy years, with FY20 the largest year at $175MM. Recent spend is above the prior three-year period.

Annual acquisitions + disclosed spend

count spend named deal

MEG count bars show acquisition cadence; the spend line shows when the program required larger capital deployment.

Program diagnostics

Recent / prior

16 / 9

Last three years is up 78% vs prior three.

Peak count year

FY21

6 disclosed acquisitions in the peak visible year.

Recent spend

$211MM

is up 21% vs prior three; peak FY20 at $175MM.

Named evidence

2 rows

5.4% selected source-cited transaction coverage.

Selected transactions

Date	Target	Segment	Consideration ($MM)	Strategic rationale	Source
Apr 1, 2020	The Center for Toxicology and Environmental Health, L.L.C.	Core solid waste, recycling, and environmental services	$243	In April 2020, the Company completed the acquisition of CTEH by acquiring 100.0% of its membership interests. CTEH is an environmental consulting company headquartered in Arkans...	10-K^†
Aug 1, 2019	Emerging Compounds Treatments Technologies, Inc.	Core solid waste, recycling, and environmental services	$54	In August 2019, the Company acquired 100.0% of the issued and outstanding capital stock of Emerging Compounds Treatments Technologies, Inc. (“ECT2”), a provider of novel technol...	10-K^†

Acquisitions disclosed/extracted from SEC filings; not necessarily full M&A history. Disclosed acquisition cash outflow is cumulative "payments for acquisitions, net of cash acquired" from the 10-K cash-flow statements (a cash outflow, not deal value). Built on 4 SEC-backed facts across 1 cited filings.

Evidence

Source archive

A collapsed investigation trail for the SEC filings behind the financials, annual M&A cadence, named transactions, and management language.

Annual 10-Ks

Named deal filings

Recent SEC filings

Evidence clips

Annual 10-K M&A evidenceAccepted annual filings used for disclosed acquisition count and spend.4 rows+

Fiscal year	Filing date	Form	Status	Count	Cash spend	Purchase consideration	Source
FY2025	Feb 26, 2026	Annual M&A 10-K	quarantined (2 issue)	0	N/A	N/A	SEC filing
FY2024	Mar 3, 2025	Annual M&A 10-K	accepted	6	$113MM	$154MM	SEC filing
FY2022	Mar 1, 2023	Annual M&A 10-K	quarantined (1 issue)	5	$29.7MM	$34.1MM	SEC filing
FY2020	Mar 24, 2021	Annual M&A 10-K	quarantined (1 issue)	3	N/A	$244MM	SEC filing

Named transaction source filingsFilings behind selected named-deal rows and transaction excerpts.1 rows+

Filing date	Form	Targets / topics	Support	Source
Mar 24, 2021	10-K	The Center for Toxicology and Environmental Health, L.L.C.; Emerging Compounds Treatments Technologies, Inc.	Annual M&ANamed deals	SEC filing

Recent SEC filingsThe latest profile filings, kept separate so someone can investigate beyond M&A.0 rows+

No filing source clears this category.

Evidence clipsShort excerpts used on the page; expand only when you want the language.2 rows+

The Center for Toxicology and Environmental Health, L.L.C.

10-K - Mar 24, 2021

Medium

In April 2020, the Company completed the acquisition of CTEH by acquiring 100.0% of its membership interests. CTEH is an environmental consulting company headquartered in Arkansas that specializes ...

SEC source

Emerging Compounds Treatments Technologies, Inc.